GDL Leasing & Finance is a non-banking financial company that provides microfinance loans and credit facilities to individuals and small businesses, primarily earning income through interest and processing fees.
The company operates in a highly fragmented and commoditized lending market with no evidence of low-cost funding or proprietary distribution. While margins appear high, the extremely low return on equity and lack of scale suggest the absence of any durable competitive advantage.
Management has recently increased authorized capital and conducted private placements to expand the loan book, but historical returns on capital are poor. Reinvestment has not yet translated into meaningful per-share value or efficient asset utilization.
The investment collapsed after the auditor's inability to verify the loan book proved to be a harbinger of systemic asset quality issues. Regulatory authorities intervened following the discovery of interest rate violations in Rajasthan, leading to massive fines and a forced suspension of operations. As the company lacked a low-cost funding base or proprietary distribution, the sudden withdrawal of related-party support and the inability to raise fresh capital caused the loan book to shrink, leaving shareholders with a shell company that generated returns far below the cost of capital.
RichFakir rates GDL Leasing & Finance Ltd's business quality as poor — 35/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, GDL Leasing & Finance Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on GDL Leasing & Finance Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of GDL Leasing & Finance Ltd's fair value is about ₹4 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →